手法を比較

	Fugl-Meyer Assessment	ミニバランス評価システムテスト（Mini-BESTest）	NIHSS：National Institutes of Health Stroke Scale
分野	リハビリテーション	リハビリテーション	神経学
系統	Process / pipeline	Process / pipeline	Process / pipeline
提唱年	1975	2009	1989
提唱者	Fugl-Meyer, Jääskö, Leyman	Horak, Wrisley, Frank	Thomas Brott and NIH Stroke Study Group
種類	Performance-based clinical scale	Performance-based test	Clinician-rated
原典	Fugl-Meyer, A. R., Jääskö, L., Leyman, I., Olsson, S., & Steglind, S. (1975). The post-stroke hemiplegic patient: a method for evaluation of physical performance. Scandinavian Journal of Rehabilitation Medicine, 7(2), 13–31.	Horak, F. B., Wrisley, D. M., & Frank, J. (2009). The Balance Evaluation Systems Test (BESTest): using organization of sensory inputs and motor output to identify balance deficits. Physical Therapy, 89(5), 484–498.	Brott, T., Adams, H. P., Olinger, C. P., et al. (1989). Measurements of acute cerebral infarction: A clinical examination scale. Stroke, 20(7), 864-870.
別名	FMA, Fugl-Meyer Scale, FMA Stroke	Mini-BESTest, BESTest, Balance Evaluation Systems Test	NIH Stroke Scale
関連	3	1	5
概要	The Fugl-Meyer Assessment (FMA) is a comprehensive, clinician-administered scale measuring sensorimotor recovery and motor impairment in stroke patients. Developed by Fugl-Meyer and colleagues in 1975, FMA has become the gold standard outcome measure in stroke rehabilitation research and clinical practice for quantifying motor recovery in the upper extremity, lower extremity, balance, and sensation.	The Mini-Balance Evaluation Systems Test (Mini-BESTest) is a brief performance-based measure of balance impairment designed to identify the underlying sensory, motor, and cognitive contributions to balance deficits. Developed by Franchignoni and colleagues in 2010 as a shortened version of the comprehensive BESTest, Mini-BESTest is ideal for clinical use, assessing balance function in 10–15 minutes and helping guide targeted rehabilitation.	The NIHSS is the standard acute stroke severity assessment tool used in emergency departments, stroke centers, and clinical trials worldwide. Developed by the NIH Stroke Study Group in 1989, the 15-item scale provides rapid, reproducible quantification of acute neurological deficit from ischemic or hemorrhagic stroke. NIHSS scores inform thrombolytic and thrombectomy eligibility, predict outcomes, and serve as primary endpoint in stroke intervention trials.